Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models | Zendy

Rocío GallegoDurán | Zendy; Leticia ÁlvarezAmor | Zendy; Antonio GilGómez | Zendy; Ángela Rojas | Zendy; Rocío MúñozHernández | Zendy; Antonio Cádernas-García | Zendy; Douglas MayaMiles | Zendy; Rocío MonteroVallejo | Zendy; Sheila Gato | Zendy; Yolanda Sánchez Torrijos | Zendy; Javier Ampuero | Zendy; Franz Martı́n | Zendy; Manuel RomeroGómez | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models

Author(s) -

Rocío GallegoDurán,

Leticia ÁlvarezAmor,

Antonio GilGómez,

Ángela Rojas,

Rocío MúñozHernández,

Antonio Cádernas-García,

Douglas MayaMiles,

Rocío MonteroVallejo,

Sheila Gato,

Yolanda Sánchez Torrijos,

Javier Ampuero,

Franz Martı́n,

Manuel RomeroGómez

Publication year - 2019

Publication title -

revista española de enfermedades digestivas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.331

H-Index - 38

eISSN - 2340-4167

pISSN - 1130-0108

DOI - 10.17235/reed.2019.6083/2018

Subject(s) - fatty liver , medicine , steatosis , steatohepatitis , endocrinology , pathophysiology , histology , choline , methionine , disease , biochemistry , biology , amino acid

non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed world. Currently, there is no approved pharmacological therapy except for lifestyle intervention. Therefore, there is a need to increase the knowledge of preclinical models in order to boost novel discoveries that could lead to a better therapeutic management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research